from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0127/mak

LFCtreatmentdescriptionclass of inhibitor

0.209

Amikacinug/mL Amikacintranslation

0.147

Cap5-10ug/mL Capreomycintranslation

0.451

Rox10-50 ug/mL Roxithromycintranslation

-0.169

SM2-5 ug/mL Streptomycintranslation

1.857

Tet5-10 ug/mL Tetracyclinetranslation

0.027

Rif0.2-5ug/mL Rifampicintranscription

0.365

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.355

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.968

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.607

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.675

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.403

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.304

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.401

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.967

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.438

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.582

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.081

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.566

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.146

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.299

KCN5-20 ug/mL Potassium cyaniderespiration

-0.939

NaN30.2-2 mM Sodium aziderespiration

0.112

Nigericin50 uM Nigericinrespiration

-0.237

TRC10-150 ug/mL Triclosanrespiration

-0.711

TRZ10-25 ug/mL Thioridazinerespiration

-1.492

Valinomycin0.5-10 uM Valinomycinrespiration

-0.343

ZnSO42 mM ZnSO4respiration

-0.997

menadione6-10 ug/mL Menadionerespiration

-0.442

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.145

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.016

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.248

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.375

NRP_1Non-replicating persistence stage 1dosRassociated

0.597

Amp0.2mg/mL AmpicillincellWall

0.166

Cephalexin20-100 ug/mL CephalexincellWall

0.440

Cerulenin0.32-5 ug/mL CerulenincellWall

0.462

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.057

EMB10-20 ug/mL EthambutolcellWall

1.601

Eta12-40 ug/mL EthionamidecellWall

1.801

INH0.2-0.4 ug/mL IsoniazidcellWall

1.222

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.323

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.463

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.027

BZA0.12 mg/mL BenzamidearomaticAmides

0.153

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.380

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.059

H2O24 mM hydrogen peroxideDNAdamaging

0.041

Levo10 ug/mL LevofloxacinDNAdamaging

-0.174

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.661

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.538

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.179

UVUV-irradiationDNAdamaging

-0.668

ARP41-4 ug/mL Antitubercular compound ARP4?

2.073

Antimycin12.5-50 ug/mL Antimycin A?

-0.284

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.086

PA_110-50 ug/mL Antitubercular compound PA-1?

0.056

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.206

PA8240.2-2 ug/mL PA-824?

-0.696

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.326

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.106

Verapamil50 uM Verapamil?

0.181

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.179

methoxatin10-20 ug/mL Methoxatin?